A 32-year-old woman at 20 weeks gestation undergoes routine anatomy scan. The sonographer identifies a midline mass in the lumbosacral region with both cystic and solid components. There is no associated spinal dysraphism. The radiologist notes the mass is intimately related to the coccyx and sacrum. Based on the embryological origin from the primitive streak and caudal eminence, what is the most appropriate next step in management?

Explanation

## Embryological Basis **Key Point:** Sacrococcygeal teratomas arise from pluripotent cells of the primitive streak and caudal eminence (tail bud), which are active during gastrulation (weeks 3–4). These cells normally undergo apoptosis; failure of this process leads to teratoma formation [cite:Langman's Embryology 12e Ch 5]. ## Clinical Significance of Imaging Findings The presence of **both cystic and solid components** with **coccygeal attachment** is pathognomonic for sacrococcygeal teratoma (SCT). The next step is NOT immediate delivery but rather **comprehensive prenatal characterization** to guide management. ## Why MRI is Essential | Finding on MRI | Clinical Implication | Management Impact | |---|---|---| | Large solid component | High vascularity, risk of steal phenomenon | Plan early delivery, NICU setup | | Predominantly cystic | Lower vascularity, lower complication risk | Can plan vaginal delivery | | Polyhydramnios | Fetal cardiac failure, hydrops risk | Urgent delivery planning | | Spinal cord involvement | Risk of neurological deficits | Neurosurgery consultation | **High-Yield:** MRI allows: 1. Accurate size and growth rate assessment 2. Detection of intrauterine complications (polyhydramnios, hydrops, cardiac dysfunction) 3. Prediction of neonatal morbidity and mortality 4. Optimal timing of delivery (vaginal vs. cesarean, term vs. preterm) ## Management Pathway ```mermaid flowchart TD A[Sacrococcygeal mass detected at 20 weeks]:::outcome --> B[Perform fetal MRI]:::action B --> C{Complications present?}:::decision C -->|Hydrops/polyhydramnios| D[Plan early delivery + NICU]:::action C -->|No complications| E[Monitor growth & vascularity]:::action E --> F{Progression?}:::decision F -->|Rapid growth| G[Deliver at 37-38 weeks]:::action F -->|Stable| H[Plan vaginal delivery at term]:::action D --> I[Postnatal surgical resection]:::action G --> I H --> I ``` **Clinical Pearl:** Prenatal MRI changes management in ~40% of cases by detecting complications not visible on ultrasound, allowing appropriate counseling and neonatal preparation [cite:Robbins 10e Ch 7].